S100A10 and fibrosarcoma: S100A10 plays an important role in this process, as overexpression of S100A10 in HT1080 fibrosarcoma was shown to increase the lung metastatic burden in mice by 16-fold while the loss of S100A10 reduced the metastatic burden by 3-fold [93].